Biogen/ US09062X1037 /
8/19/2022 9:45:39 PM | Chg. -2.67 | Volume | Bid9:45:41 PM | Ask9:45:41 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
213.70USD | -1.23% | 16,610 Turnover: 3.55 mill. |
170.91Bid Size: 187 | 256.41Ask Size: 100 | 31.07 bill.USD | 0.00% | 20.51 |
Fundamentals
FY 2021 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 10.44 USD | -58.00% |
EPS Diluted: | 10.40 USD | -58.06% |
Revenues per Share: | 73.65 USD | -11.85% |
Book Value per Share: | 73.51 USD | 10.68% |
Cash Flow per Share: | 24.41 USD | -7.14% |
Dividend per Share: | 0.00 USD | - |
Total | in mill. | |
Revenues: | 10,981.70 USD | -18.32% |
Net Income: | 1,556.10 USD | -61.10% |
Operating Cash Flow: | 3,639.90 USD | - |
Cash and Cash Equivalents: | 2,261.40 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 20.51 | 22.98 |
P/S Ratio: | 2.91 | 3.26 |
P/BV ratio: | 2.91 | 3.26 |
P/CF Ratio: | 8.77 | 9.83 |
PEG: | -0.35 | -0.40 |
Earnings Yield: | 4.88% | 4.35% |
Dividend Yield: | 0.00% | 0.00% |
Market Capitalization | ||
Market Capitalization: | 31.07 bill. USD | 35.77 bill. USD |
Free Float Market Cap.: | 22.44 bill. USD | 26.22 bill. USD |
Market Cap. / Employee: | 3.32 mill. USD | 3.72 mill. USD |
Shares Outstanding: | 146.45 mill. |
Profitability
Gross Profit Margin: | 100.00% |
EBIT Margin: | 25.87% |
Net Profit Margin: | 14.17% |
Return on Equity: | 14.20% |
Return on Assets: | 6.52% |
Financial Strength
Liquidity I / Cash Ratio: | 88.47% |
Liquidity II / Quick Ratio: | 124.51% |
Liquidity III / Current Ratio: | 182.79% |
Debt / Equity Ratio: | 117.86% |
Dynam. Debt / Equity Ratio: | 354.89% |
Efficiency
Employees: | 9,610 |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | 1,142,736.73 USD |
Net Income / Employee: | 161,925.08 USD |
Total Assets / Employee: | 2,484,630.59 USD |
* Fiscal Year End: | 12/31/2021 |
Accounting Standard: | US GAAP |
Currency: | USD |